Posted on

otc cbds

Bloomberg

We’ve detected unusual activity from your computer network

To continue, please click the box below to let us know you’re not a robot.

Why did this happen?

Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy.

Need Help?

For inquiries related to this message please contact our support team and provide the reference ID below.

Bloomberg We’ve detected unusual activity from your computer network To continue, please click the box below to let us know you’re not a robot. Why did this happen? Please make sure your

Cannabis Sativa, Inc. (CBDS)

Previous Close 0.7200
Open 0.7200
Bid N/A x N/A
Ask N/A x N/A
Day’s Range 0.7200 – 0.7450
52 Week Range 0.3200 – 1.8200
Volume 38,603
Avg. Volume 272,403
Market Cap 20.089M
Beta (5Y Monthly) 0.82
PE Ratio (TTM) N/A
EPS (TTM) -0.1570
Earnings Date Jun 29, 2020
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

PrestoDoctor Presents Missouri Dispensary 101 – Everything to Know About the New Missouri Dispensaries

MESQUITE, NV / ACCESSWIRE / March 9, 2021 / Cannabis Sativa, Inc. (OTCQB:CBDS) is proud to announce that PrestoDoctor \- the 1 patient-rated medical cannabis telemedicine service is presenting Missouri Dispensary 101, “Everything You Ever Wanted to Know About Our New Missouri Dispensaries from A-Z in 2021” on March 13, 2021 from 11am to 1pm Online at https://www.

PrestoDoctor Expands Cannabis Telemedicine Service to Iowa

MESQUITE, NV / ACCESSWIRE / March 2, 2021 / Cannabis Sativa, Inc. (OTCQB:CBDS) is proud to announce that PrestoDoctor \- the 1 patient-rated medical cannabis telemedicine service – now offers its online medical cannabis card service to patients in the state of Iowa.

PrestoDoctor’s Robert Tankson Featured in Forbes Next 1000 Upstart Entrepreneurs

MESQUITE, NV / ACCESSWIRE / February 18, 2021 / Cannabis Sativa, Inc. (OTCQB:CBDS) is proud to announce that PrestoDoctor’s Rob Tankson is featured in Forbes Next 1000 Upstart Entrepreneurs redefining the American Dream.

Cannabis Sativa Reports $459,786 Revenue in Q3, Revenues for Nine Months ended September 30 up 137% over first 3 Quarters of 2019

Mesquite, Nov. 17, 2020 (GLOBE NEWSWIRE) — MESQUITE, NV / November 17, 2020 / Cannabis Sativa, Inc. (OTCQB:CBDS) reports revenues of $459,786 for Q3, and $1,674,021 for the nine months ended September 30, 2020, up 137% compared to the nine months ended September 30, 2019. “We are pleased to report strong numbers during this pandemic as our telemedicine portal PrestoDoctor (https://prestodoctor.com) helps patients in California, Nevada, New York, Oklahoma, Missouri, Pennsylvania and Illinois seeking medical cannabis recommendations in the safest way” said President David Tobias. “There has been a broadened acceptance of telehealth due to the Corona virus.” The Company is currently exploring expansion opportunities in additional states, including Ohio, Virginia, and Massachusetts.PrestoDoctor’s expanded market area and heightened advertising have been driving an increase in patient visits to our online platform and a general expansion in consumer awareness of the PrestoDoctor brand. PrestoDoctor reported $1,602,599 revenues in those nine months ended September 30, 2020.GK Manufacturing and Packaging subsidiary was in the start-up phase for the nine months ended September 30, 2020. Revenue and operating efficiencies were impacted by the pandemic, as was the learning curve required for the labor force to become familiar with the manufacturing equipment, the cost of moving into a new facility, and the need to build a backlog of customer orders to streamline the production process. The start-up phase has taken longer than expected, primarily due to the pandemic, however management expects these negative factors to lessen in the coming periods and is currently focused on building its customer base and product line. “The CBD product market in the U. S. is estimated at over $1.7 Billion in 2020, and GK Manufacturing & Packaging, as a CBD product formulator, contract manufacturer, and fulfillment center is poised to gain greater market share in 2021 as celebrity brands and start-up brands needing our services continue to emerge”, Tobias stated.About PrestoDoctor PrestoDoctor is rated the 1 online medical marijuana doctor by tens of thousands of medical cannabis patients who have received fully qualified medical marijuana recommendations. PrestoDoctor is the only service to offer patients a custom treatment plan after they have a confidential evaluation with a licensed, highly knowledgeable physician who is an expert in treatment methods, dosing levels, and cannabis products. Founded in 2015, PrestoDoctor services are available in legal medical marijuana states: California, Missouri, New York, Nevada, Oklahoma, Pennsylvania, and Illinois. A HIPAA and HITECH compliant telemedicine company, PrestoDoctor is a member of the American Telemedicine Association (ATA), maintaining the highest customer satisfaction rating for any telemedicine service online with over 14,000 5-star reviews www.prestodoctor.comAbout GK Manufacturing & Packaging: GK Manufacturing (http://gkmanufacturinginc.com) is a Southern California based contract manufacturing, co-packing and white label company, producing a wide range of highest quality, lab-tested CBD products including edibles, tinctures, drinks and topicals. GK specializes in short batch runs, formulation, mixology, graphics/labeling and fulfillment. In-house brands include the well-established Ganja Juice brand, Canna Science,and Murray & Roccos CBD infused pet line. Shop their new portal at (https://cbdinit.com).Cannabis Sativa, Inc. (CBDS) is engaged in telehealth, contract manufacturing CBD infused products, and the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. CBDS holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, and operates subsidiaries including: PrestoDoctor® (https://prestodoctor.com), GK Manufacturing & Packaging (http://gkmanufacturinginc.com), Wild Earth Naturals® (https://wildearthnaturals.com), and iBudtender (https://ibudtender.com). The Company licenses the hi and White Rabbit brands, and is the official licensee for Virgin Mary Jane Brand (https://virginmaryjanebrand.com).Forward Looking Statements: This press release contains forward-looking statements. Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Contact Information: (702) 762-3123 https://www.cannabissativa.com

PrestoDoctor Co-Founder Rob Tankson to Speak at “Bridging the Gap” Medical Cannabis Conference

MEDICAL CANNABIS CONFERENCE 2020 Bridging the GapMesquite, NV, Oct. 13, 2020 (GLOBE NEWSWIRE) — MESQUITE, NV/ October 13, 2020 / Cannabis Sativa, Inc. (OTCQB: CBDS) proudly announces that Rob Tankson, COO and co-founder of PrestoDoctor will be a featured speaker at The Medical Cannabis Conference 2020 at the University of Toronto Scarborough on October 13, 2020. Bridging the Gap: Exploring Potential Links Between Academia and the Medical Cannabis Industry features leading experts in business and academia discussing pressing issues impacting the global industry. “PrestoDoctor made a strategic decision to educate our patients about cannabis products, usage methods, and more,” COO Tankson said. “Scientific research documenting and exploring the benefits of cannabis is essential to bridge the gap between helping society and using cannabis as a medicine. I’m pleased to be chosen to speak to such a luminary crowd about our experience”. Mr Tankson is scheduled to present on Tuesday, October 13, 2020 9:10–10:00 am ET Kick-off Panel: Connecting Academia with Industry 3:15–4:00 pm ET Mergers and Acquisitions in the Global Cannabis Industry About PrestoDoctor PrestoDoctor is rated the 1 online medical marijuana doctor by tens of thousands of medical cannabis patients who have received fully qualified medical marijuana recommendations. PrestoDoctor is the only service to offer patients a custom treatment plan after they have a confidential evaluation with a licensed, highly knowledgeable physician who is an expert in treatment methods, dosing levels, and cannabis products. Founded in 2015, PrestoDoctor services are available in legal medical marijuana states: California, Missouri, New York, Nevada, Oklahoma, Pennsylvania, and Illinois. A HIPAA and HITECH compliant telemedicine company, PrestoDoctor is a member of the American Telemedicine Association (ATA), maintaining the highest customer satisfaction rating for any telemedicine service online with over 14,000 5-star reviews www.prestodoctor.com About GK Manufacturing & Packaging: GK Manufacturing is a Southern California based contract manufacturing, co-packing, and white label company, producing a wide range of highest quality, lab-tested CBD products including edibles, tinctures, drinks and topicals. GK specializes in short batch runs, formulation, mixology, graphics/labeling, and fulfillment. In–house brands include the well-established Ganja Juice brand (http://ganja-juice.com),Canna Science, and Murray & Rocco’s CBD infused pet line. About Cannabis Sativa, Inc.: Cannabis Sativa, Inc. (“CBDS”) is engaged in telehealth, contract manufacturing CBD infused products, and the licensing of cannabis-related intellectual property, marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. CBDS holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, and operates subsidiaries including: PrestoDoctor® (https://prestodoctor.com), GK Manufacturing & Packaging (http://gkmanufacturinginc.com), Wild Earth Naturals® (https://wildearthnaturals.com), and iBudtender (https://ibudtender.com). The Company licenses the “hi” and “White Rabbit” brands and is the official licensee for Virgin Mary Jane Brand (https://virginmaryjanebrand.com). Forward-Looking Statements: This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Contact Information: (702) 762-3123 https://www.cannabissativa.comAttachment * MEDICAL CANNABIS CONFERENCE 2020 CONTACT: (702) 762-3123 https://cannabissativainc.com

Cannabis Sativa Allowed HI Mark by USPTO as Pending

hi shirts w forbes quote Bet a lot of other pot startups will be wishing they grabbed that branding first girl walking in hi tshirt GET HIMesquite, NV, Aug. 27, 2020 (GLOBE NEWSWIRE) — MESQUITE, NV / August 27, 2020 / Cannabis Sativa, Inc. (OTCQB: CBDS) announces that the US Patent and Trademark Office has allowed pending the “HI” Trademark, US Trademark Application Number 86550730 on August 18, 2020. “We are pleased to culminate what has been a tenuous application process for an important brand which had been objected to by a major Canadian cannabis company and has since been settled” said CEO David Tobias.” Federal trademark protection for marijuana products has been and still is unavailable because cannabis can’t be lawfully sold across state lines. “A decision was made by management to file for brand protection under the apparel category until change occurs”, CEO Tobias stated. Shoppers can visit our online store at https://wildearthnaturals.com/collections/all.About PrestoDoctorPrestoDoctor is rated the 1 online medical marijuana doctor by tens of thousands of medical cannabis patients who have received fully qualified medical marijuana recommendations. PrestoDoctor is the only service to offer patients a custom treatment plan after they have a confidential evaluation with a licensed, highly knowledgeable physician who is an expert in treatment methods, dosing levels, and cannabis products. Founded in 2015, PrestoDoctor services are available in legal medical marijuana states: California, Missouri, New York, Nevada, Oklahoma, Pennsylvania, and Illinois. A HIPAA and HITECH compliant telemedicine company, PrestoDoctor is a member of the American Telemedicine Association (ATA), maintaining the highest customer satisfaction rating for any telemedicine service online with over 14,000 5-star reviews www.prestodoctor.comAbout GK Manufacturing & Packaging:GK Manufacturing is a Southern California based contract manufacturing, co-packing and white label company, producing a wide range of highest quality, lab-tested CBD products including edibles, tinctures, drinks and topicals. GK specializes in short batch runs, formulation, mixology, graphics/labeling and fulfillment. In–house brands include the well-established Ganja Juice brand (http://ganja-juice.com),Canna Science, and Murray & Rocco’s CBD infused pet line.About Cannabis Sativa, Inc.:Cannabis Sativa, Inc. (“CBDS”) is engaged in telehealth, contract manufacturing CBD infused products, and the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. CBDS holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, and operates subsidiaries including: PrestoDoctor® (https://prestodoctor.com), GK Manufacturing & Packaging (http://gkmanufacturinginc.com), Wild Earth Naturals® (https://wildearthnaturals.com), and iBudtender (https://ibudtender.com). The Company licenses the “hi” and “White Rabbit” brands, and is the official licensee for Virgin Mary Jane Brand (https://virginmaryjanebrand.com).Forward Looking Statements:This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.Contact Information:(702) 762-3123https://www.cannabissativa.comAttachments * hi shirts w forbes quote * girl walking in hi tshirt

PrestoDoctor Expands Cannabis Telemedicine Service to Illinois

Mesquite,NV, Aug. 18, 2020 (GLOBE NEWSWIRE) — Cannabis Sativa, Inc. (OTCQB: CBDS) is proud to announce that the 1 patient-rated medical cannabis telemedicine service PrestoDoctor (https://prestodoctor.com/) now offers their online medical cannabis recommendation services to patients in the state of Illinois. Founded in 2015, PrestoDoctor has provided experienced and compassionate telemedicine care to more than 100,000 patients in six states and is pleased to begin offering the same quality of service to patients in Illinois.“Our proprietary telemedicine portal is now providing Illinois cannabis patients with easy and confidential access and education via an online appointment with a knowledgeable licensed medical doctor,” said Rob Tankson, PrestoDoctor co-founder. “We expect Illinois patients to be very pleased with our service and value.”Cannabis Sativa CEO David Tobias stated, “Illinois is yet another large market opportunity for PrestoDoctor. The PrestoDoctor team continues to perform and increase market share, and has targeted more states to come online in 2020. Robust demand in New York, Oklahoma, Missouri and Pennsylvania fuel expectations that Illinois will produce substantial appointments, continuing their current trend of increasing revenues.”About PrestoDoctor PrestoDoctor is rated the 1 online medical marijuana doctor by tens of thousands of medical cannabis patients who have received fully qualified medical marijuana recommendations. PrestoDoctor is the only service to offer patients a custom treatment plan after they have a confidential evaluation with a licensed, highly knowledgeable physician who is an expert in treatment methods, dosing levels, and cannabis products. Founded in 2015, PrestoDoctor services are available in legal medical marijuana states: California, Missouri, New York, Nevada, Oklahoma, Pennsylvania, and Illinois. A HIPAA and HITECH compliant telemedicine company, PrestoDoctor is a member of the American Telemedicine Association (ATA), maintaining the highest customer satisfaction rating for any telemedicine service online with over 14,000 5-star reviews www.prestodoctor.comAbout Cannabis Sativa, Inc.:Cannabis Sativa, Inc. (“CBDS”) is engaged in telehealth, contract manufacturing CBD infused products, and the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. CBDS holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, and operates subsidiaries including: PrestoDoctor® (https://prestodoctor.com), GK Manufacturing & Packaging (http://gkmanufacturinginc.com), Wild Earth Naturals® (https://wildearthnaturals.com), and iBudtender (https://ibudtender.com). The Company licenses the “hi” and “White Rabbit” brands, and is the official licensee for Virgin Mary Jane Brand (https://virginmaryjanebrand.com).Forward Looking Statements:This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.Contact Information:(702) 762-3123https://www.cannabissativa.com

CBDS Reports Q2 Revenues Up 377% From Q2 2019 as Telemedicine Mainstreams

Mesquite, NV, Aug. 14, 2020 (GLOBE NEWSWIRE) — Cannabis Sativa, Inc. (CBDS) announces Q2 Revenues of $721,095 and gross profit of $438,812 for the three months ended June 30, 2020. On a percentage basis this represents growth of 377% and 439% for revenue and gross profit, respectively, for the three months compared to the same period in 2019. For the six-month period ended June 30, 2020, revenues and gross margins were $1,214,235 and $744,617, respectively. This represents growth of 383% and 447%, respectively, when compared to the six months ended June 30, 2019. “The telehealth sector overall has seen explosive growth, and CBDS’ increases are a result of the improved business operations of PrestoCorp, our 51% owned subsidiary doing business as PrestoDoctor (https://prestodoctor.com/) said President David Tobias. PrestoDoctor continues to exceed expectations as people stay home, work from home, and practice social distancing while using telemedicine.President Trump’s recently signed Executive Order to Improve Rural Health and Telehealth Access replaces temporary Public Health Emergency (“PHE”) rules. The new mandate permanently allows telehealth across state borders and gives PrestoDoctor expanded opportunities to provide services in states that were previously only tempraryliy available via the PHE rules. “These developments are expected to have a positive impact on revenues in the coming periods,” President David Tobias stated.In addition, GK Manufacturing and Packaging, Inc. (“GKMP”), our 51% owned subsidiary providing contract manufacturing of cannabidiol (“CBD”) infused products to national and regional customers, is expected to provide substantial revenues by Q4 2020. GKMP is currently producing white label products infused with CBD for a range of customers, and is beginning to build a backlog of repeat orders that extend through the end of the year. Cannabis Sativa has invested over $400,000 into GMP to fund the start-up operations to date and expects to invest up to $100,000 as additional working capital during the ramp up phase.About PrestoDoctor:PrestoDoctor launched in California in the summer of 2015, and has since expanded into Nevada, New York, Oklahoma, Missouri and Pennsylvania. PrestoDoctor has facilitated over a hundred thousand appointments and maintains the highest customer satisfaction rating for any telemedicine service online. PrestoDoctor has over 14,000 5-star reviews, and is the first medical marijuana company to be accepted into the American Telemedicine Association. PrestoDoctor is HIPAA and HITECH compliant. PrestoDoctor plans to continue to expand its services in 2020.About GK Manufacturing & Packaging:GK Manufacturing is a Southern California based contract manufacturing, co-packing and white label company, producing a wide range of highest quality, lab-tested CBD products including edibles, tinctures, drinks and topicals. GK specializes in short batch runs, formulation, mixology, graphics/labeling and fulfillment. In–house brands include the well-established Ganja Juice brand (ganja-juice.com),Canna Science, and Murray & Rocco’s CBD infused pet line.About Cannabis Sativa, Inc.:Cannabis Sativa, Inc. (“CBDS”) is engaged in telehealth, contract manufacturing CBD infused products, and the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. CBDS holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, and operates subsidiaries including: PrestoDoctor® (https://prestodoctor.com), GK Manufacturing & Packaging (http://gkmanufacturinginc.com), Wild Earth Naturals® (https://wildearthnaturals.com), and iBudtender (https://ibudtender.com). The Company licenses the “hi” and “White Rabbit” brands, and is the official licensee for Virgin Mary Jane Brand (https://virginmaryjanebrand.com).Forward Looking Statements:This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.Contact Information:(702) 762-3123https://www.cannabissativa.com

TELEHEALTH MADE PERMANENT ACROSS STATE LINES A BIG WIN FOR PRESTODOCTOR AND AMERICA

MESQUITE, NV, Aug. 06, 2020 (GLOBE NEWSWIRE) — TELEHEALTH MADE PERMANENT ACROSS STATE LINES A BIG WIN FOR PRESTODOCTOR AND AMERICAMESQUITE, NV / August 6, 2020 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces big news for PrestoDoctor following President Trump’s signing of an Executive Order on Improving Rural Health and Telehealth Access. This gives PrestoDoctor greatly improved opportunities in providing services to states that prior to this mandate were only available to telehealth via the Public Health Emergency. “This new Executive Order will greatly help our current telemedicine service model as well as future expansion plans,” said CEO David Tobias. “Thousands of people who live in rural areas as well as urban residents can now access trustworthy medical advice on how to use cannabis.” https://www.whitehouse.gov/presidential-actions/executive-order-improving-rural-health-telehealth-access/The Executive Order mandates in Sec. 5. Expanding Flexibilities Beyond the Public Health Emergency that “Within 60 days of the date of this order, the Secretary shall review the following temporary measures put in place during the PHE, and shall propose a regulation to extend these measures, as appropriate, beyond the duration of the PHE.The Centers for Medicare & Medicaid Services (CMS) is also proposing changes to expand telehealth permanently, consistent with the Executive Order that President Trump signed August 3 to improve access and convenience of care, particularly in rural areas.Per Sec. 3. Investments in Physical and Communications Infrastructure, it states that “Within 30 days of the date of this order, the Secretary and the Secretary of Agriculture shall, consistent with applicable law and subject to the availability of appropriations, and in coordination with the Federal Communications Commission and other executive departments and agencies, as appropriate, develop and implement a strategy to improve rural health by improving the physical and communications healthcare infrastructure available to rural Americans”.PrestoDoctor launched in California in the summer of 2015, and has since expanded into Nevada, New York, Oklahoma, Missouri, and Pennsylvania. PrestoDoctor has facilitated over a hundred thousand appointments and maintains the highest customer satisfaction rating for any telemedicine service online. PrestoDoctor has over 14,000 5-star reviews and is the first medical marijuana company to be accepted into the American Telemedicine Association. PrestoDoctor is HIPAA and HITECH compliant. PrestoDoctor plans to continue to expand its services in 2020.About PrestoDoctor:PrestoDoctor launched in California in the summer of 2015, and has since expanded into Nevada, New York, Oklahoma, Missouri and Pennsylvania. PrestoDoctor has facilitated over a hundred thousand appointments and maintains the highest customer satisfaction rating for any telemedicine service online. PrestoDoctor has over 4,000 5-star reviews, and is the first medical marijuana company to be accepted into the American Telemedicine Association. PrestoDoctor is HIPAA and HITECH compliant. PrestoDoctor plans to continue to expand its services in 2020.About Cannabis Sativa, Inc.:Cannabis Sativa, Inc. (“CBDS”) is engaged in telehealth, contract manufacturing CBD infused products, and the licensing of cannabis related intellectual property, marketing and branding for cannabis based products and services, operation of cannabis related technology services, and ancillary business activities. CBDS holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, a U.S. Patent for a marijuana lozenge; a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery and trade secret formulas and processes, and operates subsidiaries including: PrestoDoctor® (https://prestodoctor.com), GK Manufacturing & Packaging (http://gkmanufacturinginc.com), Wild Earth Naturals® (https://wildearthnaturals.com), and iBudtender (https://ibudtender.com). The Company licenses the “hi” and “White Rabbit” brands, and is the official licensee for Virgin Mary Jane Brand (https://virginmaryjanebrand.com).Forward Looking Statements: This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Contact Information:(702) 762-3123https://www.cannabissativa.com

PrestoDoctor Co-Founder Rob Tankson Discusses the Cannabis Evaluation Experience in Forbes Interview

Mesquite, NV, July 16, 2020 — tankson (1) ROB TANKSONMESQUITE, NV / Cannabis Sativa, Inc. (CBDS) PrestoDoctor co-founder Rob Tankson discusses “deepening the cannabis.

Find the latest CANNABIS SATIVA INC (CBDS) stock quote, history, news and other vital information to help you with your stock trading and investing.